advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International Partnership For Microbicides

The International Partnerships for Microbicides (IPM) is a nonprofit organization that developed the monthly dapivirine ring, and is dedicated to accelerating the development and availability of other new HIV prevention tools for women in developing countries.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC delivers statement on WHO R&D observatory, pooled fund at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) calling for the rapid operationalization and full funding for the World Health Organization Global Observatory on Health Research and Development and supporting efforts to establish a health R&D pooled fund. The statement, which was issued in partnership with the Global Health Council and PATH, also encourages exploration of innovative funding sources to attract new funding for the observatory and pooled fund and calls for continued transparency to ensure these operations are grounded in sound science and public health.

PATH/Gabe Bienczycki
IP Watch covers GHTC co-hosted event

IP Watch covered the May 22 WHA side-event entitled "Investing in Innovative Health R&D Tools to Address Antimicrobial Resistance and Achieve the SDGs" hosted by GHTC, COHRED, PATH, TB Alliance, MMV, and GHC.

View All News & Events

Community Event

McGill University
McGill Summer Institute in Infectious Diseases and Global Health
McGill University
Learn More
View All Events
USAID celebrates 50 years of saving lives across the globe

Today, the US Agency for International Development (USAID) celebrates 50 years of leadership and expertise in addressing development challenges to improve lives across the globe.

Read More
Step One

Don Joseph is Chief Operating Officer at BIO Ventures for Global Health (BVGH), a GHTC member, and wrote this blog post in conjunction with the launch of WIPO Re:Search, a new consortium where public and private sector organizations share valuable intellectual property (IP) and expertise with the global health research community to promote development of new drugs, vaccines, and diagnostics to treat neglected tropical diseases, malaria, and tuberculosis.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide